First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Article (Journal) |
| Language: | English |
| Published: |
26 March 2019
|
| In: |
Cancer chemotherapy and pharmacology
Year: 2019, Volume: 83, Issue: 6, Pages: 1057-1063 |
| ISSN: | 1432-0843 |
| DOI: | 10.1007/s00280-019-03796-4 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00280-019-03796-4
|
| Author Notes: | Christophe Massard, Jean‑Charles Soria, Jürgen Krauss, Michael Gordon, Albert Craig Lockhart, Erik Rasmussen, Vijay V. Upreti, Sonal Patel, Gataree Ngarmchamnanrith, Haby Henary |
| Item Description: | Gesehen am 18.07.2019 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1432-0843 |
| DOI: | 10.1007/s00280-019-03796-4 |